PRME Prime Medicine, Inc.
Healthcare$2.97+0.68%ClosedMarket Cap: $536.4M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$17.25
Target (Median)
$17.00
Target Range
$12.00 - $23.00
Upside from current price: 480.8%
Rating Distribution
1 Strong Buy8 Buy4 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2025-11-11 | Citigroup | maintain | Neutral | Neutral |
| 2025-11-10 | Chardan Capital | maintain | Buy | Buy |
| 2025-08-12 | Citigroup | maintain | Neutral | Neutral |
| 2025-08-08 | Chardan Capital | maintain | Buy | Buy |
| 2025-05-27 | Citigroup | downgrade | Neutral | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.91 | $22.5M | 7 |
| Sun Dec 31 | $-0.81 | $31.3M | 7 |
| Mon Dec 31 | $-0.93 | $18.4M | 2 |
| Tue Dec 31 | $-0.82 | $60.1M | 5 |